Deerfield
About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More
---
Investment

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More
---
Information

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---
Philanthropy

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
---
Portfolio Companies

Deerfield generally maintains a combined portfolio of more than 150 private and public investments across the life science, medical device, diagnostic, digital health and health service industries at all stages of evolution from start-up to mature company.

Read More View Portfolio Companies
---
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More View Research Collaborations
---
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Read More
---
Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
---
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

PE Hub: Every disease is a finite puzzle

PE Hub’s ongoing series on private equity firms investing in healthcare continues with insights from Jim Flynn, Deerfield Managing Partner

“Every drug since 2010, was invented by a university and by partnering with over 20 large universities, we are teaming up with the source of innovation and hopefully that leads to a differentiated return,” said Deerfield’s Jim Flynn

Download the article to read more

This article should not be construed as an offer to sell, or a solicitation to buy, any security or instrument in, or to participate in any investment strategy with any funds, vehicles or accounts sponsored or managed by Deerfield Management Company, L.P. (“Deerfield”) or any portfolio company in which Deerfield has invested. The list of portfolio companies provided herein is not a complete list of all current or historical portfolio companies. To learn more, please see the Portfolio Company section of Deerfield’s website at www.Deerfield.com. PE Hub has been compensated for the right to redistribute this article. PE Hub is not affiliated with Deerfield and was not compensated to publish this article on Deerfield’s behalf. While Deerfield believes the content of the article is accurate, Deerfield makes no representation or warranty as to the accuracy or completeness of the information provided herein. It should not be assumed that any current, former, or future investments were or will be profitable. There is no guarantee that other opportunities will have similar characteristics or results to those described in this article.